Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Poland,Netherlands,Spain,Ireland,Slovakia,Latvia,Italy,Sweden,Czech Republic,Ukraine - Phase: terminated
nct
MAJ Il y a 5 ans
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
The purpose of the protocol is to assess the efficacy and safety of BIM 23A760 on patient's overall satisfaction in terms of symptom relief (diarrhoea and/or flushes) in patients with carcinoid syndrome after 24 weeks of treatment.
Pays
Austria
,
Belgium
,
Czech Republic
,
Finland
,
France
,
Germany
,
Ireland
,
Israel
,
Italy
,
Latvia
,
Netherlands
,
Poland
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Ukraine
,
United Kingdom
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1